6
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Normal overall leakiness of microvasculature for albumin in patients with chronic obstructive lung disease (COLD)

&
Pages 119-123 | Received 16 May 1983, Accepted 03 Oct 1983, Published online: 05 Aug 2009
 

Abstract

The overall extravasation rate of albumin, TER (i. e. the fraction of the intravascular albumin mass (IVM) passing into, and during steady state returning from, the extravascular space per unit time) was determined from the disappearance of i. v. injected radioiodinated serum albumin in seven patients with severe chronic obstructive lung disease (COLD) and in seven normal controls. Arterial oxygen tension in patients with COLD was median 60 mmHg (range 47-80 normal >75 mmHg), vital capacity was on the average 55% of expected normal value (median 1.80 litre, range 1.45–1.95), and forced expired volume in first sec was decreased to 21% of expected normal value (median 0.55 litre, range 0.40–0.70). Right-heart catheterization revealed pulmonary hypertension in all but one patient. TER in patients with COLD was median 6.1% IVM/h (range 3.5–10.1) as compared to that of normal controls 6.0% IVM/h (range 4.3–7.4), indicating that no significant change in microvascular leakiness to albumin could be found in patients with COLD. Thus, the results bring no support to a generally increased microvascular permeability to proteins in patients with COLD.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.